Achieve Life Sciences's net income is $-110M, below the Technology sector average of $12T.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Loading...
Loading...
Achieve Life Sciences (ACHV) currently reports a net income of $-110M as of June 2026. That compares with $-50M in the prior-year period — down 126.2% year over year. That is below the Technology sector average of $12T. Use the charts on this page to explore Achieve Life Sciences's net income history and peer comparisons.
Achieve Life Sciences's net income decreased from $-50M to $-110M — a 126.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Achieve Life Sciences's net income of $-110M is lower than the Technology sector average of $12T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Achieve Life Sciences reported $-110M in net income as of June 2026. That compares with $-50M in the prior-year period — down 126.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current net income of $-110M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is $12T. From there, open related valuation or income-statement pages for Achieve Life Sciences, and consider following ACHV for alerts when major investors trade the stock.